ir.ipatherapeutics.comInvestor Relations - ImmunoPrecise Antibodies Ltd.

ir.ipatherapeutics.com Profile

Ir.ipatherapeutics.com is a subdomain of Ipatherapeutics.com, which was created on 2022-02-18,making it 2 years ago.

Discover ir.ipatherapeutics.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site

ir.ipatherapeutics.com Information

HomePage size: 98.337 KB
Page Load Time: 0.121377 Seconds
Website IP Address: 162.159.130.11

ir.ipatherapeutics.com Similar Website

Masonite International Corp. - Investor Relations - Investor Relations
investor.masonite.com
Block, Inc. (SQ) Investor Relations - Investor Relations
investors.block.xyz
Gen Investor Relations - Investor Relations
investor.gendigital.com
MindChamps PreSchool Limited - Investor Relations: Investor Relations
investor.mindchamps.org
Home - Ayala Land Investor Relations : Ayala Land Investor Relations
ir.ayalaland.com.ph
Universal Technical Institute's Investor Relations - UTI Investor Relations
uti.investorroom.com
Ameriprise Financial Investor Relations | Investor Relations
ir.ameriprise.com
Meridian Bank Investor Relations - Meridian Bank Investor Relations
investor.meridianbanker.com
Armstrong World Industries Investor Relations | Armstrong Flooring Investor Relations
ir.armstrong.com
Walmart Investor Relations - Investor Relations
stock.walmart.com
Alphabet Investor Relations - Investor Relations - Alphabet
investor.google.com
Investor Relations | Jacobs - Investor Relations
invest.jacobs.com

ir.ipatherapeutics.com PopUrls

Investor Relations - ImmunoPrecise Antibodies Ltd.
https://ir.ipatherapeutics.com/overview/default.aspx
Financials - Quarterly Results - ImmunoPrecise Antibodies Ltd.
https://ir.ipatherapeutics.com/financials/quarterly-results/default.aspx
Stock Info - ImmunoPrecise Antibodies Ltd.
https://ir.ipatherapeutics.com/stock-info/default.aspx
News Releases - ImmunoPrecise Antibodies Ltd.
https://ir.ipatherapeutics.com/news/news-releases/default.aspx
Governance Documents - ImmunoPrecise Antibodies Ltd.
https://ir.ipatherapeutics.com/governance/governance-documents/default.aspx
Financials - Annual Reports
https://ir.ipatherapeutics.com/financials/annual-reports/default.aspx
Events & Presentations - ImmunoPrecise Antibodies Ltd.
https://ir.ipatherapeutics.com/events-and-presentations/default.aspx
Governance - Committee Composition
https://ir.ipatherapeutics.com/governance/committee-composition/default.aspx
Resources - Investor Contacts
https://ir.ipatherapeutics.com/resources/investor-contacts/default.aspx
IPA Reports Financial Results and Recent Business Highlights for Third ...
https://ir.ipatherapeutics.com/news/news-releases/news-details/2023/IPA-Reports-Financial-Results-and-Recent-Business-Highlights-for-Third-Quarter-Fis
IPA Reports Financial Results and Recent Business Highlights for Second ...
https://ir.ipatherapeutics.com/news/news-releases/news-details/2023/IPA-Reports-Financial-Results-and-Recent-Business-Highlights-for-Second-Quarter-Fi
IPA Reports Financial Results and Recent Business Highlights for Second ...
https://ir.ipatherapeutics.com/news/news-releases/news-details/2022/IPA-Reports-Financial-Results-and-Recent-Business-Highlights-for-Second-Quarter-Fi
ImmunoPrecise Reports Financial Results and Recent Business Highlights ...
https://ir.ipatherapeutics.com/news/news-releases/news-details/2023/ImmunoPrecise-Reports-Financial-Results-and-Recent-Business-Highlights-for-Full-Fi
IPA Announces Closing of $1.265 Million Public Offering of Common ...
https://ir.ipatherapeutics.com/news/news-releases/news-details/2023/IPA-Announces-Closing-of-1.265-Million-Public-Offering-of-Common-Shares/default.as
IPA to Report Financial Results and Recent Business Highlights for ...
https://ir.ipatherapeutics.com/news/news-releases/news-details/2023/IPA-to-Report-Financial-Results-and-Recent-Business-Highlights-for-Fourth-Quarter-

ir.ipatherapeutics.com Httpheader

Date: Tue, 14 May 2024 08:26:47 GMT
Content-Type: text/html; charset=utf-8
Transfer-Encoding: chunked
Connection: keep-alive
CF-Ray: 8839815e88728404-LAX
CF-Cache-Status: REVALIDATED
Cache-Control: public, max-age=10, stale-if-error=86400, stale-while-revalidate=86400
Last-Modified: Tue, 14 May 2024 08:26:47 GMT
Strict-Transport-Security: max-age=31536000; includeSubDomains
Vary: Accept-Encoding
X-Content-Type-Options: nosniff
X-Frame-Options: SAMEORIGIN
X-XSS-Protection: 1; mode=block
Server: cloudflare

ir.ipatherapeutics.com Meta Info

content="text/html; charset=utf-8" http-equiv="Content-type"/
content="RevealTrans(Duration=0,Transition=0)" http-equiv="Page-Enter"/
content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/
content="width=device-width, initial-scale=1" name="viewport"/
content="default-src 'self' https: http: 'unsafe-inline' 'unsafe-eval' *.q4inc.com; script-src 'self' *.bootstrapcdn.com *.datatables.net *.cloudfront.net *.pusherapp.com *.newrelic.com *.nr-data.net *.bugherd.com *.q4cdn.com *.q4web.com *.amazonaws.com *.highcharts.com *.googletagmanager.com *.googleadservices.com *.google-analytics.com *.google.com *.gstatic.com *.q4app.com *.pendo.io 'unsafe-inline' 'unsafe-eval' *.q4inc.com" http-equiv="Content-Security-Policy"/
content="XZHBpW-cPfPYXgkaDdwzIP8uWtZysn790gGX1tV9Y6g" name="google-site-verification"/

ir.ipatherapeutics.com Html To Plain Text

Overview News News Releases In the Media Events & Presentations Stock Info Stock Quote Stock Chart Historical Stock Quote Investment Calculator Dividend History Analyst Coverage Financials Quarterly Results Annual Reports SEC Filings Governance Governance Documents Executive Management Board of Directors Committee Composition Resources Information Request Form Investor Email Alerts Investor Contacts Overview News News Releases In the Media Events & Presentations Stock Info Stock Quote Stock Chart Historical Stock Quote Investment Calculator Dividend History Analyst Coverage Financials Quarterly Results Annual Reports SEC Filings Governance Governance Documents Executive Management Board of Directors Committee Composition Resources Information Request Form Investor Email Alerts Investor Contacts Corporate Overview IPA’s proprietary technologies and products are positioned on the leading edge of antibody development, innovating our industry as a single source provider of the full complement of antibody discovery platforms. As an investor in IPA, you’re joining us at the forefront of new, exciting, and valuable advancements in next-generation antibody discovery. Learn more Latest News View All News in French Latest Events View All View All Follow us follow us on twitter follow us on linkedin follow us on facebook IR Contact Lorem ipsum dolor Position000-0000-0000[email protected] Main Website https://www.ipatherapeutics.com/ Email Alerts To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At ImmunoPrecise Antibodies Ltd., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to ImmunoPrecise Antibodies Ltd. to send you the requested Investor Email Alert updates. * Required Email Address * Investor Alert Options Investor Alert Options * News Events & Presentations Quarterly Reports Annual Reports SEC Filings EOD Stock Quote Unsubscribe Email Alert Sign Up Confirmation Request a meeting with management Privacy Policy Cookies Policy Terms of Use ©2023 ImmunoPrecise Antibodies LTD. All rights reserved. IPA is a trademark of ImmunoPrecise Antibodies LTD. Powered By Q4 Inc. 5.122.0.3 (opens in new...

ir.ipatherapeutics.com Whois

Domain Name: IPATHERAPEUTICS.COM Registry Domain ID: 2676176966_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-10-03T07:11:55Z Creation Date: 2022-02-18T21:16:55Z Registry Expiry Date: 2027-02-18T21:16:55Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS01.DOMAINCONTROL.COM Name Server: NS02.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T23:18:02Z <<<